Double-blind, placebo-controlled efficacy and safety study of lisdexamfetamine dimesylate in adolescents with attention-deficit/ hyperactivity disorder

Authors
Category Primary study
ConferenceNeuropsychopharmacology
Year 2010
This article has no abstract
Epistemonikos ID: 4560b00899829b23b3febfd1ef4f745d47ceffb5
First added on: Apr 30, 2026